[Personality characteristics in patients with Wilson's lichen ruber planus].

Z. Puchalski,L. Szlendak

1981-02-01

Abstract:

What problem does this paper attempt to address?

Study on antigenic protein Omp2b in combination with Omp31 and BP26 for serological detection of human brucellosis

Qi Wu,Lei Yuan,Xiaohan Guo,Mingjun Sun,Meixue Yao,Dehui Yin

DOI: https://doi.org/10.1016/j.mimet.2022.106663

Abstract:Background: Brucellosis is a very common zoonosis in certain localized areas worldwide, with a high prevalence in most developing countries. The detection of brucellosis still faces many challenges such as the need for more sensitive and specific diagnostic antigens. Methods: To evaluate the efficacy of Brucella outer membrane proteins (Omps) Omp2b in combination with omp31 and BP26 as diagnostic antigens for the serological detection of human brucellosis, these proteins were prepared by a prokaryotic expression system. Human brucellosis-positive and-negative sera were collected, and the detection effects of the diagnostic antigens were evaluated using an established indirect ELISA (iELISA) method. Receiver operating characteristic (ROC) curves and the area under the ROC curve (AUC), true positives, true negatives, false positives, false negatives, accuracy, positive predictive value, negative predictive value, analytical specificity, and sensitivity were obtained to evaluate the effectiveness of Omp2b and antigen combinations. Results: The iELISA results showed that the AUC of the antigenic proteins was 0.9100, 0.9387, 0.9343, and 0.9448, respectively, and that the combination of Omp31 and BP26 improved the accuracy and was superior to that of Omp2b alone. Analysis at the determined cut-off values showed that the analytical sensitivity of the assay was 0.8739 (95% CI:0.7974-0.9293) and the analytical specificity was 0.8539 (95% CI:0.7632-0.9199) when using Omp2b alone and 0.8649 when using the combination of Omp2b + BP26 (95% CI:0.7869-0.9223) with an analytical specificity of 0.9213 (95% CI:0.8446-0.9678) and 0.8468 (95% CI:0.7662-0.9082) and an analytical sensitivity of 0.9101 (95% CI:0.8305-0.9604). When Omp2b + Omp31 + BP26 was combined, the analytical sensitivity and specificity were 0.8559 (95% CI:0.7765-0.9153) and 0.9326 (95% CI:0.8590-0.9749), respectively. Protein antigens, including antigen combinations, did not cross-react with Yersinia enterocolitica O9 and E. coli O157: H7, indicating that their specificity was better than that of lipopolysaccharide (LPS). Conclusions: Compared with individual Omp2b, antigen combinations improved the effectiveness in detecting brucellosis, but were still not as effective as LPS antigen. Omp2b, combined with Omp31 and BP26 as diagnostic antigens, can be used to detect human brucellosis.
The outer membrane proteins based seroprevalence strategy for Brucella ovis natural infection in sheep

Tao Zhang,Yu Wang,Yin Li,Tingting Qi,Zhirong Yue,Lili Cao,Bo Zhou,Huping Jiao

DOI: https://doi.org/10.3389/fcimb.2023.1189368

IF: 6.073

2023-06-14

Frontiers in Cellular and Infection Microbiology

Abstract:Introduction: The diagnosis of brucellosis largely relies on tiger red plate agglutination test (RBPT). However, it is difficult to distinguish between natural infection antibody positive and vaccination antibody positive, nevertheless, the identification of specific Brucella species natural infection. Methods: Here, we analyzed the structure of main outer membrane proteins (OMPs), OMP25 and OMP31 from Brucella ovis ( B. ovis ) and Brucella melitensis ( B. melitensis ), which are the main pathogens of sheep brucellosis, and found the OMP25 and OMP31 could be used as the differential antigens for B. ovis and B. melitensis antibody. Then we expressed the OMP25 from B. ovis (OMP25o) and OMP31 from B. melitensis (OMP31m). Results: They have equally efficiency in antibody detection of vaccinated sheep serum, consistent with the RBPT results. However, through epidemiological investigations, we found some RBPT positive samples were negative by the OMP31m based serum antibody detection, but these samples gave positive results by the OMP25o. We verified these OMP31m negative but OMP25o positive samples by B. ovis and B. melitensis specific primers based PCR detection, and all these samples were B. melitensis negative. However, four out of six samples are B. ovis positive. These results showed that we could use the OMP25o and OMP31m to diagnose sheep brucellosis antibody, especially to discriminate the infection of the B. ovis . Discussion: Currently, China has not yet approved a vaccine based on B. ovis and B. ovis positive samples should be naturally infected. There should be some implicit transmission of B. ovis in Jilin province. Further epidemiological investigation should be conducted to monitor the B. ovis natural infection.

immunology,microbiology
Evaluation of Reactivity of Monoclonal Antibodies Against Omp25 of Brucella spp

Xin Yang,Zuoping He,Guoxia Zhang,Jinhui Lu,Hui Zhang,Hui Ren,Yanjun Tian,Heng Yang,Chuangfu Chen,Linhai Li,Yongshui Fu,Jean-Pierre Allain,Chengyao Li,Wenjing Wang

DOI: https://doi.org/10.3389/fcimb.2020.00145

2020-04-21

Abstract:Brucellosis is a serious zoonosis occurring mainly in developing countries, and its diagnosis is largely dependent on serologic detection and bacterial culture. In this study, we developed the murine monoclonal antibodies (mAbs) against a conserved and major outer membrane protein 25 (Omp25) of Brucella species (B. spp.) for use in clinical diagnosis. The mAbs to Omp25 were produced by hybridoma technique, which were utilized for developing various immunoassays for detection of Brucellae, including Western blot (WB), enzyme-linked immunosorbent assay (ELISA), immunochemical staining (ICS), immunofluorescence staining (IFS), and flow cytometry assay (FCM). A number of five mAbs (2B10, 4A12, 4F10, 6C12, and 8F3) specific to Omp25 were selected, including 2 IgG1, 2 IgG2a, and 1 IgG2b. Among them, mAbs 6C12, 8F3, and 4A12 reacted highly with B. melitensis (M5-90), B. abortus (S19, 104M, and 2308), and B. suis strain (S2). No cross-reactivity with Yersinia enterocolitica O:9, Salmonella spp., and Escherichia coli was found. By mapping Omp25 epitopes, mAb 6C12 was found as reacting with a semi-conformational epitope, and mAbs 4A12 and 8F3 as recognizing a different linear epitope, respectively. The paired mAbs were tested for detecting Brucella species, suggesting that 8F3 was suitable for solid phase capture and 6C12 or 4A12 was suitable for conjugation with HRP for detection of Brucella Omp25 in ELISA. The FCM was established by mAb 6C12 for detecting intracellular Brucellae-infected peripheral blood mononuclear cells (PBMCs) from brucellosis patients. In conclusion, mAbs against Omp25 are precious reagents for detection of Brucellae in clinical samples with various immunoassays. mAb 6C12-based FCM could be potentially used for the monitoring of therapeutic efficacy for brucellosis in clinical practice.
Watermelon stomach revealing generalized essential telangiectasia

F. Tétart,A. Lorthioir,N. Girszyn,L. Lahaxe,P. Ducrotte,I. Marie

DOI: https://doi.org/10.1111/j.1445-5994.2009.02048.x

2009-11-01

Abstract:1 Boffard KD, Goosen J, Plani F, Degiannis E, Potgieter H. The use of low dosage x-ray (Lodox/Statscan) in major trauma: comparison between low dose x-ray and conventional x-ray techniques. J Trauma 2006; 60: 1175–81. 2 Beningfield S, Potgieter H, Nicol A, van As S, Bowie G, Hering E et al. Report on a new type of trauma full-body digital X-ray machine. Emerg Radiol 2003; 10: 23–9. 3 Mulligan ME, Flye CW. Initial experience with Lodox Statscan imaging system for detecting injuries of the pelvis and appendicular skeleton. Emerg Radiol 2006; 13: 129–33. 4 Douglas TS, Sanders V, Pitcher R, van As AB. Early detection of fractures with low-dose digital X-ray images in a pediatric trauma unit. J Trauma 2008; 65: 4–7. 5 Exadaktylos AK, Benneker LM, Jeger V, Martinolli L, Bonel HM, Eggli S et al. X-ray in trauma. An experience report on the first operational full body scanner in Europe and its possible role in ATLS. Injury 2008; 39: 525–9. 6 Schaller BB, Exadaktylos AK, Andres RH, Bonel HM. A new full body low-dose x-ray technique is an alternative to conventional ‘shunt series’ in patients with ventriculoperitoneal shunt dysfunction. Am J Emerg Med 2007; 27: 702–3.
Evaluation of chimeric proteins for serological diagnosis of brucellosis in cattle

Aitbay K. Bulashev,Bakytkali K. Ingirbay,Kanatbek N. Mukantayev,Alfiya S. Syzdykova

DOI: https://doi.org/10.14202/vetworld.2021.2187-2196

2021-08-24

Veterinary World

Abstract:Background and Aim: An accurate diagnosis of Brucella-infected animals is one of the critical measures in eradication programs. Conventional serological tests based on whole-cell (WC) antigens and detecting antibodies against pathogen-associated lipopolysaccharide might give false-positive results due to the cross-reactivity with other closely related bacteria. This study evaluated the serological potential of Brucella spp. chimeric outer membrane proteins (Omps) as antigens in an indirect enzyme-linked immunosorbent assay (i-ELISA). Materials and Methods: The chimeric gene constructs of the most immunodominant regions of Brucella Omps 25+31, 25+19, and 19+31 were cloned into the pET28a expression vectors and transformed into Escherichia coli BL21 (DE3). The serological potential of chimeric proteins compared with single recombinant Omps (rOmps)19, 25, and/or 31 were studied on blood serum samples of (i) a rabbit immunized with killed Brucella abortus 19WC, (ii) mice immunized with single rOmps, (iii) cows seropositive for brucellosis by rose Bengal test, and (iv) cattle naturally and/or experimentally infected with brucellosis. Results: E. coli BL21 actively produced Brucella chimeric rOmps, the concentration of which reached a maximum level at 6 h after isopropyl-β-D-1-thiogalactopyranoside stimulation. Target proteins were antigenic and expressed in an active state, as recognized by rabbit anti-B. abortus antibodies in an i-ELISA and western blotting. Murine antibodies against the single rOmps reacted with chimeric antigens, and conversely, antichimeric antibodies found their epitopes in single proteins. Brucella chimeric rOmps showed higher antigenicity in blood sera of seropositive cattle kept in the hotbed of the infection and/or experimentally challenged with brucellosis than single proteins. Conclusion: Brucella chimeric recombinant outer membrane proteins could be a potential antigen candidate for developing an ELISA test for accurate diagnosis of bovine brucellosis.
Development of a diagnostic indirect ELISA test for detection of Brucella antibody using recombinant outer membrane protein 16 kDa (rOMP16)

Mehdi Golchin,Somayye Mollayi,Elham Mohammadi,Neda Eskandarzade

DOI: https://doi.org/10.30466/vrf.2021.524590.3141

Abstract:Brucellosis is considered as one of the important global zoonotic diseases that causes medical as well as economic problems especially in tropical countries. The illness has no specific pathognomonic signs; therefore, the rapid and accurate diagnosis of the disease has a very important role in preventing the Brucella spillover and treatment. The purpose of this study was to design a new indirect ELISA test for detection of human brucellosis based on using recombinant Brucella abortus outer membrane protein 16 kDa (rOMP16) as an antigen. OMP16 gene of B. abortus was initially synthesized and cloned in pET-21d vector and then expressed in Escherichia coli cells. The expression was confirmed by the SDS-PAGE, western blotting and dot blotting. The purified protein was coated in ELISA plates and an indirect ELISA was performed on 70 human serum samples. The results were evaluated with a commercial IgG ELISA kit and Rose Bengal plate agglutination tests as reference tests. Diagnostic performance of designed OMP16 ELISA test in comparison with Rose Bengal plate test revealed 100% of sensitivity, 95.00% of specificity and good Fleiss kappa agreement, whereas, where it was compared to commercial ELISA kit, it revealed very good kappa agreement with 100% of sensitivity and 100% of specificity in cut-off value of 0.13. It was concluded that OMP 16 kDa could be acceptable alternative antigen for detecting Brucella IgG antibody with high accuracy.
Antihistamines in daily practice: Italian allergologists' opinion.

A. Musarra,G. Senna,C. Lombardi

2013-02-01

European Annals of Allergy and Clinical Immunology

Abstract:Anti-histamines represent the mainstay of the treatment of allergic rhinitis and urticaria (1-2). However, as in every chronic condition, adherence to the therapy is relevant and a regular long-term use is more effective than an use on demand in both these conditions (3). The present survey investigated doctors’ opinions about the use of antihistamines, and looked for criticisms and unmet needs that may affect their regular use and, hence, adherence to therapy (4). A total of 147 Italian allergoloists answered a web questionnaire, structured in 9 items, from April to September 2011. Filled forms were evaluated by the beginning of October 2011. Using a Visual Analogue Scale (VAS) participants were asked to score the relevance of different pharmacological properties of antihistamines, including safety, rapidity of onset of action, and practicality.With the same tool (VAS) different drug formulations for daily use were investigated. Most respondents prescribed only (58%) or mainly (42%) second generation anti-histamines. All the studied features were considered highly important for long term use, although safety (9.0) scored slight higher than onset of action (8.2) and practicality (8.2). Fast dissolving tablets (8.8) and tablets (8.2) were considered more suitable than drops (7.0) or spray (5.2). Seventy one (71%) of participants disregarded the difficulty in swallowing the tablet as a fairly small problem, as, according to their opinion, not more then 20% of patients complained about this. Nevertheless, many allergists (45%) considered an oral dissolving tablet the most suitable form for daily usage and 68% believed that this formulation may also have a quicker onset of action. One third (32%) considered such formulation an important factor to improve the adherence to the treatment, being suitable for all ages according to 72% of allergologists. Finally, 55% consider a lyophilized formula particularly useful in the management of acute conditions, such as exacerbations of allergic rhinitis, acute urticaria or anaphylaxis. Adherence to the treatment plays a crucial role in successful long term therapy (4). Although education and a good doctor-patient relationship are important, other factors, such as an easy schedule and drug formulation, cannot be considered trivial. In fact, a better compliance has been recorded when drugs are administered once rather than twice or several times daily (5). In this study most specialists prescribed second generation anti-histamines, being these drugs less sedating, better tolerated, and generally administered once/daily. Swallowing difficulties were underestimated by most participants; in fact, according to other studies, 26% to 52% of patients have problems in swallowing oral drug formulations (tablets, capsules) (6, 7), and 50% fail to take medication when no water is available (7). Although the belief that fast dissolving tablets have a quicker onset of action is not supported by clear evidence (7), such formulations can be suggested to very young, elderly, or bed ridden patients, and to busy or travelling patients as well. In conclusion, the availability of different forms of antihistamines represents an opportunity to chose the most suitable formulation for each patient. This may enhance the adherence to the treatment and therefore its outcome; thus being cost-effective in the long term.
Recombinant Omp2b antigen-based ELISA is an efficient tool for specific serodiagnosis of animal brucellosis

Melody Vatankhah,Nazanin Beheshti,Shiva Mirkalantari,Nima Khoramabadi,Haniyeh Aghababa,Mehdi Mahdavi

DOI: https://doi.org/10.1007/s42770-019-00097-z

Abstract:Control of brucellosis as a worldwide zoonotic disease is based on vaccination of animals and diagnosis of infected cases to be eradicated. Accurate and rapid detection of infected animals is of critical importance for preventing the spread of disease. Current detection of brucellosis is based on whole-cell antigens and investigating serum antibodies against Brucella lipopolysaccharide (LPS). The critical disadvantage is misdiagnosis of vaccinated animals as infected ones and also cross-reactions with other Gram-negative bacteria. Recombinant outer membrane protein 2b (Omp2b) of Brucella abortus was evaluated as a novel serodiagnostic target in comparison to conventional tests which are based on LPS. Recombinant Omp2b (rOmp2b) was expressed in Escherichia coli BL21 and purified by Ni2+-based chromatography. rOmp2b was evaluated in an indirect enzyme-linked immunosorbent assay (ELISA) system for diagnosis of brucellosis, with sera from Brucella-infected mice along with negative sera and sera from mice which were inoculated with other Gram-negative species for assurance of specificity. Thereafter, cattle sera collected from different regions were assessed along with known negative and known positive serum samples. We found that Omp2b can discriminate between Brucella-infected animals and non-infected ones. Results for assessment of two hundred and fifty cattle sera by Omp2b-based indirect ELISA which were compared to Rose Bengal plate agglutination test (RBPT) and serum tube agglutination test (SAT) showed that our proposed procedure has the sensitivity of 88.5%, specificity of 100%, and accuracy of 90.8%. We suggest that recombinant Omp2b could be used as a protein antigen for diagnosis of brucellosis in domestic animals and can be evaluated for detection of human brucellosis.
Establishment of PCR for Detecting Bovine Brucella

WANG Su-hua,WANG Zhong-cai,DU Ai-fang

DOI: https://doi.org/10.3969/j.issn.1671-7236.2012.04.018

2012-01-01

Abstract:A pair of primers were designed according to the sequence of specific Brucella gene of Outer membrane protein(OMP31),the OMP31 gene was amplified by PCR and cloned into pMD18-T vector,and then the gene sequence was detected.The results showed that the target gene band at a length 602 bp was amplified by PCR,with a homology of 99.7% to the gene sequence reported in GenBank.The experiments had proved that PCR assay possessed a high specificity,DNA bands couldn't amplified in other bacterial except Brucella.And the sensitivity test results indicated that PCR assay was more sensitive,which could detect OMP31 with only 0.9 pg/μL DNA.The successfully construction of the PCR assay provides strongly technical support for detection,identification and epidemiological investigations of bovine brucellosis.
Evaluation of the combined use of the recombinant Brucella abortus Omp10, Omp19 and Omp28 proteins for the clinical diagnosis of bovine brucellosis

Hannah Leah Tadeja Simborio,Jin Ju Lee,Alisha Wehdnesday Bernardo Reyes,Huynh Tan Hop,Lauren Togonon Arayan,Wongi Min,Hu Jang Lee,Han Sang Yoo,Suk Kim

DOI: https://doi.org/10.1016/j.micpath.2015.05.004

Abstract:Currently, there are several serodiagnostic tools available for brucellosis, however, it is difficult to differentiate an active infection from vaccination. Hence, there is a great need to develop alternative means that can distinguish between these two conditions without utilizing lipopolysaccharide (LPS). This study was an attempt to determine the efficacy of combined recombinant Brucella (B.) abortus outer membrane proteins (rOmps) and individual rOmps in the serodiagnosis of brucellosis by enzyme linked immunosorbent assay (ELISA), utilizing both that standard tube agglutination test (TAT)-positive and -negative serum samples from Korean native cattle. The results are very interesting and promising because the combined rOmp antigens used in the study were highly reactive with the TAT-positive serum samples. The combined rOmps sensitivity, specificity and accuracy were 215/232 (92.67%), 294/298 (98.66%) and 509/530 (96.04%), respectively. While these results are preliminary, the tests performed have very high potential in the serodiagnosis of brucellosis and likewise, the combined rOmps can be used for future vaccine production.
Limitations of the BP26 protein-based indirect enzyme-linked immunosorbent assay for diagnosis of Brucellosis

Ting Xin,Hongjun Yang,Nan Wang,Fang Wang,Peng Zhao,Haiguang Wang,Kairong Mao,Hongfei Zhu,Jiabo Ding

DOI: https://doi.org/10.1128/CVI.00052-13

Abstract:Brucellosis is a serious zoonosis that occurs worldwide, and its diagnosis is typically based on the detection of antibodies against Brucella lipopolysaccharide (LPS). However, the specificity of the LPS-based test is compromised by cross-reactivity with Escherichia coli O157:H7 and Yersinia enterocolitica O:9. Also, diagnosis based on the LPS test cannot differentiate between vaccinated and infected individuals. The detection of the 26-kDa cytosoluble protein (BP26) antibody is considered an alternative that circumvents these drawbacks because it is exclusively expressed by infectious Brucella. A BP26-based enzyme-linked immunosorbent assay (ELISA) has been tried for the diagnosis of Brucella-infected animals and humans, but a few results showed that BP26 couldn't react with all Brucella-positive sera. In order to explore whether different animals could produce antibodies against BP26 after being infected with various Brucella species, we infected sheep, goats, and beef cattle with common virulent reference Brucella species. All sera were collected from the experimental animals and tested using both LPS-based ELISAs and BP26-based ELISAs. The results showed that all Brucella-infected individuals could produce high levels of antibodies against LPS, but only B. melitensis 16M- and B. melitensis M28-infected sheep and B. melitensis 16M- and B. abortus 2308-infected goats could produce antibodies against BP26. Therefore, we concluded that the BP26-based indirect ELISA (i-ELISA) showed both Brucella species and host specificity, which obviously limits its reliability as a substitute for the traditional LPS-based ELISA for the detection of brucellosis.
Overexpression of transient receptor potential vanilloid 2 is associated with poor prognosis in patients with esophageal squamous cell carcinoma

K. Zhou,Shuishen Zhang,Yan Yan,Song Zhao

DOI: https://doi.org/10.1007/s12032-014-0017-5

2014-05-31

Medical Oncology

Abstract:
Comprehensive Identification of Immunodominant Proteins of Brucella abortus and Brucella melitensis Using Antibodies in the Sera from Naturally Infected Hosts

Gamal Wareth,Murat Eravci,Christoph Weise,Uwe Roesler,Falk Melzer,Lisa D Sprague,Heinrich Neubauer,Jayaseelan Murugaiyan

DOI: https://doi.org/10.3390/ijms17050659

2016-04-30

Abstract:Brucellosis is a debilitating zoonotic disease that affects humans and animals. The diagnosis of brucellosis is challenging, as accurate species level identification is not possible with any of the currently available serology-based diagnostic methods. The present study aimed at identifying Brucella (B.) species-specific proteins from the closely related species B. abortus and B. melitensis using sera collected from naturally infected host species. Unlike earlier reported investigations with either laboratory-grown species or vaccine strains, in the present study, field strains were utilized for analysis. The label-free quantitative proteomic analysis of the naturally isolated strains of these two closely related species revealed 402 differentially expressed proteins, among which 63 and 103 proteins were found exclusively in the whole cell extracts of B. abortus and B. melitensis field strains, respectively. The sera from four different naturally infected host species, i.e., cattle, buffalo, sheep, and goat were applied to identify the immune-binding protein spots present in the whole protein extracts from the isolated B. abortus and B. melitensis field strains and resolved on two-dimensional gel electrophoresis. Comprehensive analysis revealed that 25 proteins of B. abortus and 20 proteins of B. melitensis were distinctly immunoreactive. Dihydrodipicolinate synthase, glyceraldehyde-3-phosphate dehydrogenase and lactate/malate dehydrogenase from B. abortus, amino acid ABC transporter substrate-binding protein from B. melitensis and fumarylacetoacetate hydrolase from both species were reactive with the sera of all the tested naturally infected host species. The identified proteins could be used for the design of serological assays capable of detecting pan-Brucella, B. abortus- and B. melitensis-specific antibodies.
Production and evaluation of anti-BP26 monoclonal antibodies for the serological detection of animal brucellosis

Xiaohan Guo,Mingjun Sun,Yu Guo,Yao Wu,Xin Yan,Mengda Liu,Jiaqi Li,Xiangxiang Sun,Xiaoxu Fan,Haobo Zhang,Shufang Sun,Jianlong Wang,Dehui Yin

DOI: https://doi.org/10.3389/fvets.2024.1389728

IF: 3.471

2024-06-19

Frontiers in Veterinary Science

Abstract:Brucella BP26 proves to be a highly immunogenic antigen with excellent specificity in brucellosis detection. In China, the authorized use of the Bp26-deleted vaccine M5ΔBP26 for preventing small ruminant brucellosis highlights the importance of developing accurate detection methods targeting BP26, particularly for the diagnosis of differentiation between infected and vaccinated animals (DIVA). Using the traditional mouse hybridoma technique, we successfully obtained 12 monoclonal antibodies (mAbs) targeting BP26. The efficacy of these mAbs in detecting various animal brucellosis cases using the competitive ELISA method was evaluated. Among them, only the E10 mAb exhibited significant efficiency, being inhibited by 100, 97.62, and 100% of brucellosis-positive sera from cattle, small ruminants, and canines, respectively. The E10-based competitive enzyme-linked immunosorbent assay (cELISA) outperformed the BP26-based indirect enzyme-linked immunosorbent assay (iELISA) in accuracy, particularly for cattle and small ruminant brucellosis, with cELISA sensitivity reaching 97.62% compared to 64.29% for iELISA for small ruminants. Although cELISA showed slightly lower specificity than iELISA, it still maintained high accuracy in canine brucellosis detection. The epitope of mAb E10 was identified in the amino acid sequence QPIYVYPDDKNNLKEPTITGY, suggesting its potential as a diagnostic antigen for brucellosis. In conclusion, the E10-based cELISA presents an effective means of detecting animal brucellosis, particularly significant for DIVA diagnosis in China, where the BP26-mutant vaccine is widely used.

veterinary sciences
Two cervical preparation regimens prior to surgical abortion at 10–14 weeks of gestation: A randomized clinical trial

Qingyun Guo,Zhida Qian,Lili Huang

DOI: https://doi.org/10.1080/14767058.2016.1261282

2017-11-01

Abstract:Abstract Background: The aim of the study was to determine whether same-day cervical preparation with an osmotic dilator and misoprostol was as effective and safe as overnight cervical preparation for surgical abortions at 10–14 weeks. Methods: Seventy women seeking surgical abortion at 10–14 weeks were allocated to receive one osmotic dilator 16–17 h or 6–7 h prior to an abortion. All women received misoprostol 400 μg orally 2 h before the abortion. Results: The abortion time of the same-day group was 7.42 ± 1.73 min, and that of the overnight group was 8.00 ± 2.19 min (p = 0.23). The blood loss volume of the same-day group was 20.6 ± 10.6 mL, and that of the overnight group was 16.3 ± 7.0 mL (p = 0.55). The degree of cervical dilation for the same-day group was inferior to the overnight group (p = 0.02). Conclusions: Same-day cervical preparation with misoprostol and an osmotic dilator shortens the hospitalization days, suggesting same-day cervical preparation is safe, effective, and feasible for surgical abortion at 10–14 weeks of gestation.
Paper-based ELISA diagnosis technology for human brucellosis based on a multiepitope fusion protein

Dehui Yin,Qiongqiong Bai,Xiling Wu,Han Li,Jihong Shao,Mingjun Sun,Hai Jiang,Jingpeng Zhang

DOI: https://doi.org/10.1371/journal.pntd.0009695

2021-08-17

Abstract:Background: Brucellosis, as a serious zoonotic infectious disease, has been recognized as a re-emerging disease in the developing countries worldwide. In china, the incidence of brucellosis is increasing each year, seriously threatening the health of humans as well as animal populations. Despite a quite number of diagnostic methods currently being used for brucellosis, innovative technologies are still needed for its rapid and accurate diagnosis, especially in area where traditional diagnostic is unavailable. Methodology/principal findings: In this study, a total of 22 B cell linear epitopes were predicted from five Brucella outer membrane proteins (OMPs) using an immunoinformatic approach. These epitopes were then chemically synthesized, and with the method of indirect ELISA (iELISA), each of them displayed a certain degree of capability in identifying human brucellosis positive sera. Subsequently, a fusion protein consisting of the 22 predicted epitopes was prokaryotically expressed and used as diagnostic antigen in a newly established brucellosis testing method, nano-ZnO modified paper-based ELISA (nano-p-ELISA). According to the verifying test using a collection of sera collected from brucellosis and non-brucellosis patients, the sensitivity and specificity of multiepitope based nano-p-ELISA were 92.38% and 98.35% respectively. The positive predictive value was 98.26% and the negative predictive value was 91.67%. The multiepitope based fusion protein also displayed significantly higher specificity than Brucella lipopolysaccharide (LPS) antigen. Conclusions: B cell epitopes are important candidates for serologically testing brucellosis. Multiepitope fusion protein based nano-p-ELISA displayed significantly sensitivity and specificity compared to Brucella LPS antigen. The strategy applied in this study will be helpful to develop rapid and accurate diagnostic method for brucellosis in human as well as animal populations.
Evaluating the efficacy of serological testing of clinical specimens collected from patients with suspected brucellosis

Nannan Xu,Chunmei Qu,Lintao Sai,Sai Wen,Lulu Yang,Shanshan Wang,Hui Yang,Hui Liu,Gang Wang

DOI: https://doi.org/10.1371/journal.pntd.0011131

2023-02-23

PLoS Neglected Tropical Diseases

Abstract:This study aims to evaluate the efficacy of the standard agglutination test (SAT), the Brucellacapt test and enzyme-linked immunosorbent assay (ELISA) in clinical specimens collected from patients with suspected brucellosis. A prospective study was conducted from December 2020 to December 2021. Brucellosis was diagnosed on the basis of clinical evidence, and confirmed by isolation of Brucella or a four-fold rise in SAT titer. All samples were tested by the SAT, ELISA and the Brucellacapt test. Titers ≥1:100 were considered as SAT positive; ELISA was considered positive when an index greater than 11 was detected, while titers ≥1/160 indicated positivity on the Brucellacapt test. The specificity, sensitivity, and positive (PPVs) and negative predictive values (NPVs) of the three different methods were calculated. A total of 149 samples were collected from patients with suspected brucellosis. The sensitivities for the SAT, IgG, and IgM detection were 74.42%, 88.37% and 74.42%, respectively. The specificities were 95.24%, 93.65%, and 88.89%, respectively. The simultaneous measurement of IgG and IgM improved the sensitivity (98.84%) but reduced the specificity (84.13%) compared to each antibody test separately. The Brucellacapt test had excellent specificity (100%) and a high PPV (100%); however, the sensitivity and NPV were 88.37% and 86.30%, respectively. The combination of IgG detection by ELISA and the Brucellacapt test had excellent diagnostic performance, with 98.84% sensitivity and 93.65% specificity. This study showed that the simultaneous performance of IgG detection by ELISA and the Brucellacapt test has the potential to overcome the current limitations of detection. Brucellosis is an endemic zoonotic disease with significant impacts on public health worldwide. Early identification is crucial to reduce the rates of disability and mortality due to brucellosis. Human brucellosis is associated with a wide variety of clinical manifestations, making it difficult to diagnose clinically. Serological tests, which lack specificity and produce results that may be difficult to interpret, play a fundamental role in the diagnosis of this disease. Therefore, the combination of various serological tests may be helpful in ensuring the accuracy of diagnosis. Here, we aimed to explore the best combination among the SAT, ELISA and the Brucellacapt test to improve the efficiency of the diagnosis of human brucellosis.

tropical medicine,parasitology
Recurrent blanching of the tongue due to giant cell arteritis.

R. Grahame,R. Bluestone,P. Holt

DOI: https://doi.org/10.7326/0003-4819-69-4-781

IF: 39.2

1968-10-01

Annals of Internal Medicine

Abstract:Abstract A 75-year-old woman suffered from giant cell arteritis and recurrent ischemic episodes of the tongue that were stopped by treatment with prednisone. This is the first time recurrent lingua...
A Novel Multi-Epitope Recombined Protein for Diagnosis of Human Brucellosis

Dehui Yin,Li,Xiuling Song,Han Li,Juan Wang,Wen Ju,Xiaofeng Qu,Dandan Song,Yushen Liu,Xiangjun Meng,Hongqian Cao,Weiyi Song,Rizeng Meng,Jinhua Liu,Juan Li,Kun Xu

DOI: https://doi.org/10.1186/s12879-016-1552-9

IF: 3.7

2016-01-01

BMC Infectious Diseases

Abstract:Background: In epidemic regions of the world, brucellosis is a reemerging zoonosis with minimal mortality but is a serious public hygiene problem. Currently, there are various methods for brucellosis diagnosis, however few of them are available to be used to diagnose, especially for serious cross-reaction with other bacteria.Method: To overcome this disadvantage, we explored a novel multi-epitope recombinant protein as human brucellosis diagnostic antigen. We established an indirect enzyme-linked immunosorbent assay (ELISA) based on this recombinant protein. 248 sera obtained from three different groups including patients with brucellosis (146 samples), non-brucellosis patients (82 samples), and healthy individuals (20 samples) were tested by indirect ELISA. To evaluate the assay, a receiver-operating characteristic (ROC) analysis and immunoblotting were carried out using these characterized serum samples.Results: For this test, the area under the ROC curve was 0.9409 (95 % confidence interval, 0.9108 to 0.9709), and a sensitivity of 88.89 % and a specificity of 85.54 % was given with a cutoff value of 0.3865 from this ROC analysis. The Western blot results indicate that it is feasible to differentiate human brucellosis and non-brucellosis with the newly established method based on this recombinant protein.Conclusion: Our results obtained high diagnostic accuracy of the ELISA assay which encourage the use of this novel recombinant protein as diagnostic antigen to implement serological diagnosis of brucellosis.
New Ways of Thinking About Senescent Bioprosthetic Heart Valve Therapy.

R. Suri,Ahmad Edris,Faisal Hasan

DOI: https://doi.org/10.1016/j.jcin.2015.09.009

2015-11-01

Abstract:

[Personality characteristics in patients with Wilson's lichen ruber planus].

Study on antigenic protein Omp2b in combination with Omp31 and BP26 for serological detection of human brucellosis

The outer membrane proteins based seroprevalence strategy for Brucella ovis natural infection in sheep

Evaluation of Reactivity of Monoclonal Antibodies Against Omp25 of Brucella spp

Watermelon stomach revealing generalized essential telangiectasia

Evaluation of chimeric proteins for serological diagnosis of brucellosis in cattle

Development of a diagnostic indirect ELISA test for detection of Brucella antibody using recombinant outer membrane protein 16 kDa (rOMP16)

Antihistamines in daily practice: Italian allergologists' opinion.

Recombinant Omp2b antigen-based ELISA is an efficient tool for specific serodiagnosis of animal brucellosis

Establishment of PCR for Detecting Bovine Brucella

Evaluation of the combined use of the recombinant Brucella abortus Omp10, Omp19 and Omp28 proteins for the clinical diagnosis of bovine brucellosis

Limitations of the BP26 protein-based indirect enzyme-linked immunosorbent assay for diagnosis of Brucellosis

Overexpression of transient receptor potential vanilloid 2 is associated with poor prognosis in patients with esophageal squamous cell carcinoma

Comprehensive Identification of Immunodominant Proteins of Brucella abortus and Brucella melitensis Using Antibodies in the Sera from Naturally Infected Hosts

Production and evaluation of anti-BP26 monoclonal antibodies for the serological detection of animal brucellosis

Two cervical preparation regimens prior to surgical abortion at 10–14 weeks of gestation: A randomized clinical trial

Paper-based ELISA diagnosis technology for human brucellosis based on a multiepitope fusion protein

Evaluating the efficacy of serological testing of clinical specimens collected from patients with suspected brucellosis

Recurrent blanching of the tongue due to giant cell arteritis.

A Novel Multi-Epitope Recombined Protein for Diagnosis of Human Brucellosis

New Ways of Thinking About Senescent Bioprosthetic Heart Valve Therapy.